Calumet (CLMT) Common Equity (2022 - 2026)

Calumet (CLMT) has 5 years of Common Equity data on file, last reported at -$1.0 billion in Q1 2026.

• Common Equity for Q1 2026 came in at -$1.0 billion, down 20.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 20.98% YoY), and the FY2025 annual result was -$732.7 million, down 2.92% from the prior year.
• Common Equity declined to -$1.0 billion in Q1 2026 per CLMT's latest filing, from -$732.7 million in the prior quarter.
• Over five years, Common Equity peaked at -$443.2 million in Q3 2023 and troughed at -$1.0 billion in Q1 2026.
• A 5-year average of -$679.5 million and a median of -$672.2 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity rose 8.06% in 2023, then slumped 78.27% in 2025.
• A 5-year view of Common Equity shows it stood at -$533.3 million in 2022, then increased by 8.06% to -$490.3 million in 2023, then tumbled by 45.2% to -$711.9 million in 2024, then retreated by 2.92% to -$732.7 million in 2025, then plunged by 42.38% to -$1.0 billion in 2026.
• Business Quant data shows CLMT's Common Equity at -$1.0 billion in Q1 2026, -$732.7 million in Q4 2025, and -$695.3 million in Q3 2025.